MedTrace Logo

Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers

NCT04748536 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2021-04-26

No results posted yet for this study

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of repeat doses of IRL201104 given to healthy volunteers.

Conditions

  • Healthy Volunteer

Interventions

DRUG

IRL201104

lyophilised powder for reconstitution for IV dosing

DRUG

Placebo

Matching placebo for IRL201104

Sponsors & Collaborators

  • Revolo Biotherapeutics

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-29
Primary Completion
2021-04-05
Completion
2021-04-05

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04748536 on ClinicalTrials.gov